Rezultati - Sabine Grootenboer‐Mignot
- Showing 1 - 3 results of 3
-
1
-
2
Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus od Olivier Meyer, P. Nicaise‐Roland, Nolwenn Cadoudal, Sabine Grootenboer‐Mignot, Élisabeth Palazzo, Gilles Hayem, Philippe Dieudé, Sylvie Chollet‐Martin
Izdano 2009Artigo -
3
Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases od B. Garel, S. Oro, Daniele Afriat, C. Prost‐Squarcioni, F. Tétart, Benoît Bensaïd, Corina Bara Passot, M. Beylot‐Barry, V. Descamps, S. Duvert‐Lehembre, Sabine Grootenboer‐Mignot, G. Jeudy, A. Soria, Marie‐Blanche Valnet‐Rabier, A. Barbaud, F. Caux, Bénédicte Lebrun‐Vignes
Izdano 2018Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Dermatology
Immunology
Acne
Adverse drug reaction
Adverse effect
Anti-dsDNA antibodies
Antibody
Arthritis
Autoantibody
Biopsy
Disease
Drug
Drug eruption
Erythema multiforme
Etanercept
Gastroenterology
Glomerulonephritis
Hyperostosis
Interquartile range
Kidney
Lupus nephritis
Nephritis
Osteitis
Osteomyelitis
Pharmacology
Pharmacovigilance
Propionibacterium acnes
Pustulosis